COVID-19 and TCM: Thailand and Laos embraced China-approved Lianhua Qingwen Capsule product
Thailand and Laos were following China’s footstep in embracing a TCM formula in light of the COVID-19 pandemic.
China had added three TCM formula, namely the Lianhua Qingwen Capsule, Jinhua Qinggan Granule, and Xuebijing Injection, as part of the country’s standard therapy for COVID-19 following positive clinical trial results.
Against the backdrop, more countries were starting to embrace TCM formula, with authorisation from Thailand’s and Ecuador’s health ministry and Laos adding TCM formula to their COVID-19 treatment scheme as examples.
Taking the limelight is the TCM formula Lianhua Qingwen Capsule produced by Shijiazhuang Yiling Pharmaceutical.
